Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia

NCT00081263 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

130

Enrollment

NETWORK

Sponsor class

Conditions

Cervical Carcinoma
Cervical Intraepithelial Neoplasia Grade 2/3
Stage 0 Cervical Cancer

Interventions

DRUG: Celecoxib
OTHER: Laboratory Biomarker Analysis
OTHER: Placebo

Sponsor

Gynecologic Oncology Group

Collaborators

[object Object]